Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Mar;17(5-6):472-7.
doi: 10.1007/BF01965516.

Vascular permeability changes by proteinase inhibitors in carrageenin-induced inflammation in rats

Vascular permeability changes by proteinase inhibitors in carrageenin-induced inflammation in rats

K Watanabe et al. Agents Actions. 1986 Mar.

Abstract

The effect of proteinase inhibitors such as TLCK, TPCK and leupeptin on vascular permeability was investigated in the carrageenin-air-pouch inflammation in rats. When each inhibitor was injected into the air-pouch immediately after carrageenin injection, TLCK, TPCK and leupeptin caused a rapid and significant increase in vascular permeability. The TLCK- and TPCK-induced increase declined gradually, whereas leupeptin inhibited the vascular permeability after the temporary increase. When the inhibitors were injected 5 h after carrageenin injection, TLCK and TPCK increased the vascular permeability, whereas leupeptin was without effect. Cyproheptadine, an anti-histamine and antiserotonin drug, inhibited the leupeptin-induced temporary increase, but failed to inhibit the TLCK- and TPCK-induced increase in vascular permeability. These results suggest that the leupeptin-induced increase in vascular permeability was mediated by histamine and serotonin, while TLCK and TPCK may increase vascular permeability as a result of a direct action on endothelial cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Arthritis Rheum. 1969 Apr;12(2):103-16 - PubMed
    1. J Immunol. 1964 Aug;93:232-42 - PubMed
    1. J Clin Invest. 1977 Jul;60(1):18-31 - PubMed
    1. J Exp Med. 1968 Aug 1;128(2):259-75 - PubMed
    1. Immunology. 1963 Sep;6:478-83 - PubMed